| Organoid models of human and mouse ductal pancreatic cancer SF Boj, CI Hwang, LA Baker, IIC Chio, DD Engle, V Corbo, M Jager, ... Cell 160 (1), 324-338, 2015 | 2417 | 2015 |
| p38 mitogen-activated protein kinase regulates canonical Wnt–β-catenin signaling by inactivation of GSK3β RK Bikkavilli, ME Feigin, CC Malbon Journal of cell science 121 (21), 3598-3607, 2008 | 221 | 2008 |
| Mislocalization of the cell polarity protein scribble promotes mammary tumorigenesis and is associated with basal breast cancer ME Feigin, SD Akshinthala, K Araki, AZ Rosenberg, LB Muthuswamy, ... Cancer research 74 (11), 3180-3194, 2014 | 148 | 2014 |
| GPCRomics: GPCR expression in cancer cells and tumors identifies new, potential biomarkers and therapeutic targets PA Insel, K Sriram, SZ Wiley, A Wilderman, T Katakia, T McCann, ... Frontiers in pharmacology 9, 431, 2018 | 143 | 2018 |
| Polarity proteins regulate mammalian cell–cell junctions and cancer pathogenesis ME Feigin, SK Muthuswamy Current opinion in cell biology 21 (5), 694-700, 2009 | 126 | 2009 |
| G-protein–coupled receptor GPR161 is overexpressed in breast cancer and is a promoter of cell proliferation and invasion ME Feigin, B Xue, MC Hammell, SK Muthuswamy Proceedings of the National Academy of Sciences 111 (11), 4191-4196, 2014 | 107 | 2014 |
| Gαo mediates WNT-JNK signaling through Dishevelled 1 and 3, RhoA family members, and MEKK 1 and 4 in mammalian cells RK Bikkavilli, ME Feigin, CC Malbon Journal of Cell Science 121 (2), 234-245, 2008 | 97 | 2008 |
| Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma ME Feigin, T Garvin, P Bailey, N Waddell, DK Chang, DR Kelley, S Shuai, ... Nature genetics 49 (6), 825-833, 2017 | 79 | 2017 |
| Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma S Venkat, AA Tisdale, JR Schwarz, AA Alahmari, HC Maurer, KP Olive, ... Genome Research 30 (3), 347-360, 2020 | 70 | 2020 |
| ErbB receptors and cell polarity: new pathways and paradigms for understanding cell migration and invasion ME Feigin, SK Muthuswamy Experimental cell research 315 (4), 707-716, 2009 | 67 | 2009 |
| Dysregulation of cell polarity proteins synergize with oncogenes or the microenvironment to induce invasive behavior in epithelial cells S Chatterjee, L Seifried, ME Feigin, DL Gibbons, C Scuoppo, W Lin, ... PloS one 7 (4), e34343, 2012 | 56 | 2012 |
| RGS19 regulates Wnt–β-catenin signaling through inactivation of Gαo ME Feigin, CC Malbon Journal of cell science 120 (19), 3404-3414, 2007 | 42 | 2007 |
| Harnessing the genome for characterization of G‐protein coupled receptors in cancer pathogenesis ME Feigin The FEBS journal 280 (19), 4729-4738, 2013 | 41 | 2013 |
| Lorazepam stimulates IL6 production and is associated with poor survival outcomes in pancreatic cancer AC Cornwell, AA Tisdale, S Venkat, KE Maraszek, AA Alahmari, A George, ... Clinical Cancer Research 29 (18), 3793-3812, 2023 | 37 | 2023 |
| OSTM1 regulates β-catenin/Lef1 interaction and is required for Wnt/β-catenin signaling ME Feigin, CC Malbon Cellular signalling 20 (5), 949-957, 2008 | 32 | 2008 |
| Unintended effects of GPCR-targeted drugs on the cancer phenotype AC Cornwell, ME Feigin Trends in pharmacological sciences 41 (12), 1006-1022, 2020 | 27 | 2020 |
| Drivers of gene expression dysregulation in pancreatic cancer S Venkat, AA Alahmari, ME Feigin Trends in cancer 7 (7), 594-605, 2021 | 24 | 2021 |
| Regulation of cyclin D1 degradation by ubiquitin-specific protease 27X is critical for cancer cell proliferation and tumor growth S Alam, A Zunic, S Venkat, ME Feigin, BS Atanassov Molecular Cancer Research 20 (12), 1751-1762, 2022 | 21 | 2022 |
| Challenges and opportunities in modeling pancreatic cancer ME Feigin, DA Tuveson Cold Spring Harbor symposia on quantitative biology 81, 231-235, 2016 | 19 | 2016 |
| Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling M Doepner, I Lee, CA Natale, R Brathwaite, S Venkat, SH Kim, Y Wei, ... Science advances 8 (35), eabn4007, 2022 | 18 | 2022 |
